Physician
Qasba, Sujata
Qasba, Sujata was paid $2.58M by Medicaid between Mar 2019 and Dec 2024, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 51% of everything it billed.
33Billing provider infoQASBA, SUJATA
LAUREL, MD 20724
LAUREL, MD 20724
33aNPI1780682765assigned 07/13/2005
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$2.58M
24GClaims48,758
24DCodes billed45
24AFirst – last monthMar 2019 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Maryland
Rank by total paid#4 of 54
Median peer was paid$131K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 78 | $2K | |
| 2020 | 8,606 | $437K | |
| 2021 | 10,578 | $535K | |
| 2022 | 11,887 | $647K | |
| 2023 | 8,999 | $522K | |
| 2024incomplete | 8,610 | $438K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 51% | 16,451 | 12,862 | $1.31M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 2,364 | 2,147 | $262K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.8% | 1,962 | 1,874 | $200K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.0% | 1,713 | 1,670 | $180K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.3% | 1,821 | 1,632 | $162K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.6% | 1,255 | 1,229 | $144K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.6% | 4,507 | 4,291 | $42K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 2,520 | 2,287 | $29K |
| 90698 | 1.1% | 1,342 | 1,256 | $28K | |
| 92552 | <1% | 1,038 | 995 | $24K | |
| 90670 | <1% | 1,076 | 1,018 | $23K | |
| 90688 | <1% | 904 | 864 | $21K |
33 more codes
| 96127 | <1% | 1,842 | $16K | |
| 90680 | <1% | 703 | $15K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 870 | $14K |
| 90633 | <1% | 505 | $11K | |
| 90710 | <1% | 454 | $10K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,081 | $10K |
| 90744 | <1% | 445 | $10K | |
| 90734 | <1% | 363 | $8K | |
| D1206 | Topical application of fluoride varnish | <1% | 264 | $6K |
| 0072A | <1% | 143 | $6K | |
| 0071A | <1% | 138 | $6K | |
| 99173 | <1% | 2,247 | $6K | |
| 90686 | <1% | 260 | $5K | |
| 90677 | <1% | 233 | $5K | |
| 90620 | <1% | 200 | $4K | |
| 99381 | <1% | 52 | $3K | |
| 90651 | <1% | 159 | $3K | |
| 96161 | <1% | 911 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 13 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 42 | $2K |
| 90696 | <1% | 72 | $2K | |
| 87807 | <1% | 189 | $2K | |
| 90715 | <1% | 61 | $1K | |
| 90685 | <1% | 51 | $1K | |
| 0074A | <1% | 12 | $480.00 | |
| 90656 | <1% | 97 | $325.92 | |
| 94760 | <1% | 140 | $140.66 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 15 | $130.00 |
| H0003 | Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs | <1% | 19 | $63.40 |
| 84030 | <1% | 28 | $36.34 | |
| 91307 | <1% | 162 | $0.08 | |
| 99000 | 0% | 17 | $0.00 | |
| 36416 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.